Cerenome, Inc. (CNSY) vs Cytosorbents Corporation (CTSO)

A side-by-side comparison of Cerenome, Inc. and Cytosorbents Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CNSY

Cerenome, Inc.

$11M

$1.57HealthcareDelayed quote: Oct 6, 2026, 10:36 AM EDT

CTSO

Cytosorbents Corporation

$13M

$4.04HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT

Total return — CNSY vs CTSO

growth of $100 · dividends reinvested · last 1y

CNSY -61.5% (-61.5%/yr)CTSO -49.2% (-49.2%/yr)CTSO compounded faster over this window

CNSY CTSO

CNSY vs CTSO: by the numbers

•CTSO is the larger company ($13M vs $11M market cap).
•Both run net losses; CTSO's is the smaller (-48.94% vs -620.70% net margin).

Metrics side by side

Valuation

Metric	CNSY	CTSO
P/S ratio	2.57	0.34
P/B ratio	1.98	N/A

Profitability

Metric	CNSY	CTSO
Gross margin	89.58%	71.61%
Operating margin	-293.46%	-33.37%
Net margin	-620.70%	-48.94%
ROE	-477.54%	N/A
ROIC	-479.39%	-43.31%

Growth (annualized)

Metric	CNSY	CTSO
Revenue CAGR (5Y)	N/A	-3.17%
Total return CAGR (5Y)	N/A	-52.26%

Go deeper

Full CNSY analysis Full CTSO analysis Interactive comparison tool

Dig into the metrics

Cerenome ROE Cytosorbents ROE Cerenome operating margin Cytosorbents operating margin Cerenome revenue growth Cytosorbents revenue growth Cerenome free cash flow Cytosorbents free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.